Boosting immune response in ovarian cancer surgery
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study examines how to improve the immune system's response during ovarian cancer surgery, potentially helping the body fight the cancer better. It compares patients with ovarian cancer to women having surgery for non-cancerous conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and able to understand the study
- You have been newly diagnosed with ovarian cancer and are scheduled for surgery, or you are having surgery after chemotherapy
- You are not pregnant, breastfeeding, or have active infections or immune-suppressing conditions
- You are not taking medications that affect your immune system
- You do not have another active cancer or serious mental health condition
- You drink less than 21 units of alcohol per week
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a vaccine made from your immune cells (dendritic cell vaccine) given before chemotherapy and surgery. It aims to help your body recognize and fight ovarian cancer more effectively in people whose cancer is advanced and spread.
This study looks at how your immune system behaves around the time of planned surgery for certain breast or ovarian cancers. It may help researchers understand what immune changes happen and how they relate to your cancer.
This trial tests a new combination of two immunotherapy drugs plus standard chemotherapy before surgery for advanced ovarian cancer. The goal is to see if this treatment shrinks the cancer more and makes surgery more effective.
This study uses lab testing to create a “map” of ovarian cancer cells one cell at a time, to better understand the disease. It likely helps researchers learn which cell types are involved, using samples collected around your surgery.
This trial tests whether supervised exercise (before surgery) can help people with advanced ovarian cancer get ready for treatment. It’s meant to improve readiness and safety during the time leading up to surgery.
This study tests whether giving two commonly used medicines before surgery—one that can lower stress on the body (a beta-blocker) and one that reduces inflammation (a COX-2 inhibitor)—can improve outcomes compared with standard care. It’s for people with advanced ovarian, fallopian tube, or primary peritoneal cancer who are having open surgery.
Hear when a new Ovarian Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.